Testing effectiveness (Phase 2)Study completedNCT03212469
What this trial is testing
A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer
Who this might be right for
Head and Neck Squamous Cell CarcinomaLung CancerOesophageal Cancer
Gustave Roussy, Cancer Campus, Grand Paris 54